missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Claudin 5 Monoclonal Antibody (4C3C2), Invitrogen™
Mouse Monoclonal Antibody
Marca: Invitrogen 352500
This item is not returnable.
View return policy
Description
Claudin 5 Monoclonal antibody specifically detects Claudin 5 in Human, Mouse, Rat samples. It is validated for ELISA, Immunohistochemistry (Paraffin), Western Blot.
Specifications
Claudin 5 | |
Monoclonal | |
0.5 mg/mL | |
PBS with 0.1% sodium azide; pH 7.4 | |
O00501, O54942, Q9JKD6 | |
CLDN5 | |
Synthetic peptide derived from the mouse Claudin-5 protein | |
100 μg | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG1 |
ELISA, Immunohistochemistry (Paraffin), Western Blot | |
4C3C2 | |
Unconjugated | |
CLDN5 | |
AI854493; AWAL; BEC1; Brain endothelial cell clone 1 protein; claudin 5; claudin 5 (transmembrane protein deleted in velocardiofacial syndrome); claudin-5; claudin-5 protein; Cldn5; CPETRL1; lung-specific membrane protein; MBEC1; TMDVCF; TMVCF; Transmembrane protein deleted in VCFS; transmembrane protein deleted in velocardiofacial syndrome; Unknown (protein for MGC:138054) | |
Mouse | |
Protein A | |
RUO | |
12741, 65131, 7122 | |
-20°C | |
Liquid |
Product Suggestions
Los clientes que vieron este artículo también vieron
Viewing 1-5 of 12
Certificados
Se requiere un número de lote para mostrar resultados para certificados. Para encontrar su número de lote en pedidos anteriores, utilice el área de estado de pedidos.
1 Resultados encontrados
Número de lote | Tipo de certificado | Fecha | Catalog Number |
---|---|---|---|
AB406894 | Certificado de análisis | 27/02/2025 |
Special Offers
-
Multiple Manufacturers
Impulse la proteómica
Desbloquee avances en proteómica y ahorre de manera exclusiva.Promo Code: 25977Expires: 2025-05-31
New Offer Ahorre hasta un 92%
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Claudin 5 Monoclonal Antibody (4C3C2), Invitrogen™ > 100 μg; Unconjugated
Spot an opportunity for improvement?Share a Content Correction